FluMist Vaccine Approved for Home Use

The FDA just approved Astra Zeneca’s needle-free FluMist vaccine for self-administration at home, and the company will start mailing this live vaccine to homes across the country for the 2025-2026 flu season. Though the intranasal flu vaccine has historically accounted for a very small percentage of the total flu vaccine supply (8%), FluMist is expected to explode in growth due to its non-invasive nature and now easy access. 

https://drbowden.substack.com/p/flumist-vaccine-approved-for-home